{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:27Z","timestamp":1755216747115,"version":"3.43.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Peripheral T-cell lymphoma (PTCL) is an aggressive tumor, rarely seen in pediatrics or adolescent and young adults (AYAs) so there is no upfront or relapsed standard of care. The authors describe a 16-year-old with PTCL, treated with chemotherapy and autologous stem cell transplant. Upon relapse, he received ifosfamide, carboplatin, etoposide, and radiation with durable remission of 4 years. Data in pediatric\/AYA PCTL continue to lack an understanding of the biology and microenvironment, the differences to adult patients, and a lack of adequate therapy. Targeted therapy may improve outcomes for children and AYAs with refractory or relapsed PTCL.<\/jats:p>","DOI":"10.1097\/mph.0000000000002147","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T10:11:37Z","timestamp":1616753497000},"page":"e278-e281","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Durable Response in Relapsed Adolescent Peripheral T-cell Lymphoma: A Case Report and Review of the Literature"],"prefix":"10.1097","volume":"44","author":[{"given":"Mary Frances","family":"Wedekind","sequence":"first","affiliation":[{"name":"Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Saraf","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology\/Oncology, Indiana University, Riley Hospital for Children, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye","family":"Willen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology\/Oncology, The Ohio State University, Nationwide Children\u2019s Hospital, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony N.","family":"Audino","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology\/Oncology, The Ohio State University, Nationwide Children\u2019s Hospital, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.13216","article-title":"Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group","volume":"168","author":"Kontny","year":"2015","journal-title":"Br J Haematol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00277-016-2722-y","article-title":"Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases","volume":"95","author":"Mellgren","year":"2016","journal-title":"Ann Hematol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/bjh.15194","article-title":"Incidence and outcomes of rare paediatric non-Hodgkin lymphomas","volume":"184","author":"Sorge","year":"2019","journal-title":"Br J Haematol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pbc.21293","article-title":"Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years","volume":"50","author":"Windsor","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pbc.21543","article-title":"Non-anaplastic peripheral T-cell lymphoma in childhood and adolescence: a Children\u2019s Oncology Group study","volume":"51","author":"Hutchison","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pbc.22329","article-title":"Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in Japan","volume":"54","author":"Kobayashi","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.advms.2016.03.002","article-title":"Clinical features and treatment outcomes of peripheral T-cell lymphoma in children. A current data report from Polish Pediatric Leukemia\/Lymphoma Study Group (PPLLSG)","volume":"61","author":"Maciejka-Kemblowska","year":"2016","journal-title":"Adv Med Sci"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/MPH.0b013e3182707592","article-title":"Peripheral T-cell lymphoma in children and adolescents: a single-institution experience","volume":"34","author":"Al Mahmoud","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/ped.12784","article-title":"Spontaneous improvement in a pediatric patient with peripheral T-cell lymphoma","volume":"57","author":"Kobayashi","year":"2015","journal-title":"Pediatr Int"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.clml.2013.07.005","article-title":"A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission","volume":"13","author":"Mehta","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","article-title":"Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study","volume":"27","author":"Reimer","year":"2009","journal-title":"J Clin Oncol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d\u2019Amore","year":"2012","journal-title":"J Clin Oncol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","article-title":"Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype","volume":"120","author":"Song","year":"2003","journal-title":"Br J Haematol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/0300060516676725","article-title":"Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: a single-centre experience","volume":"45","author":"Han","year":"2017","journal-title":"J Int Med Res"},{"key":"R18-20250804","first-page":"952","article-title":"Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas","volume":"37","author":"Wang","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/bjh.15767","article-title":"Mature (non-anaplastic, non-cutaneous) T-\/NK-cell lymphomas in children, adolescents and young adults: state of the science","volume":"185","author":"Flower","year":"2019","journal-title":"Br J Haematol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/bjh.15772","article-title":"Treatment and prognosis of mature (non-anaplastic) T- and NK-cell lymphomas in childhood, adolescents, and young adults","volume":"185","author":"Xavier","year":"2019","journal-title":"Br J Haematol"},{"key":"R21-20250804","article-title":"Failure of romidepsin to treat relapsed\/refractory peripheral T-cell lymphoma in children: a single-center experience","author":"Tandon","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J Clin Oncol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/ajh.24895","article-title":"A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas","volume":"92","author":"Boonstra","year":"2017","journal-title":"Am J Hematol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11899-020-00561-w","article-title":"Brentuximab vedotin in the treatment of peripheral T cell lymphoma and cutaneous T cell lymphoma","volume":"15","author":"Shea","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:14:17Z","timestamp":1754338457000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002147","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"2020-11-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}